Frontlight ResearchEarly access
Active, not recruitingNo phase
Herpes Virus Infections in Kidney Transplant Patients
Key facts
- Who runs it
- Susanne Dam Nielsen, MD, DMSc
- Where
- Denmark5 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Active, not recruiting
- People taking part
- 280 people enrolled
- Started
- 1 Jan 2023
- Expected to end
- 31 Dec 2030
- Type of study
- Observational
- Record updated
- 12 August 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 4 criteriaShow less
Who can take part
- Kidney transplant recipient transplanted after 2019-01-01 OR on the kidney transplant waitlist
- Has been offered Shingrix® vaccination
Who cannot take part
- Lack of informed consent
- Inability to understand the study information
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Kidney transplant recipients are at increased risk of infections, including Varicella-zoster virus (VZV) infections. Vaccination against VZV is routinely offered to all kidney transplant recipients and candidates in Denmark. In this exploratory observational study, the VZV specific immune response in kidney transplant candidates and recipients will be characterized at different time points in relation to transplantation, vaccination and infections. More knowledge on the immune reaction to transplantation, VZV vaccination and VZV infections may provide improved strategies for prevention and treatment of VZV infections in kidney transplant candidates and recipients.
The group in the trial
- Kidney transplant patients
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Investigation of Kidney Transplant Patients for Antibodies and T-cells After Herpes Virus Vaccination and Infection
- Publications
- Herpes Virus Infections in Kidney Transplant Patients (HINT) - a prospective observational cohort study.BMC infectious diseases, 2023
- Record updated
- 12 August 2026